Acute generalised exanthematous pustulosis secondary to prednisolone: an unlikely suspect

De A, Das S, Sarda A, et al. Acute generalised exanthematous pustulosis: an update. Indian J Dermatol 2018; 63: 22–9. Britschgi M, Steiner U, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107: 1433–41. Meier-Schiesser B, Feldmeyer L, Jankovic D, et al. Culprit drugs induce specific IL-36 overexpression in acute generalized exanthematous pustulosis. J Invest Dermatol 2019; 139: 848–58. Marrakchi S, Guigue P, Blair R, et al. Interleukin-36-receptor antagonist deficiency and generalised pustular psoriasis. N Engl J Med 2011; 365: 620–8. Sugiura K, Takemoto A, Yamaguchi M, et al. The majority of generalised pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol 2013; 133: 2514–21. Demitsu T, Kosuge A, Yamada T. Acute generalized exanthematous pustulosis induced by dexamethasone injection. Dermatology 1996; 193: 56–8. Mussot-Chia C, Flechet ML, Napolitano M, et al. Methylprednisolone-induced acute generalized exanthematous pustulosis. Ann Dermatol Venereol 2001; 128: 241–3. Buettiker U, Keller M, Pichler WJ, et al. Oral prednisolone induced acute generalised exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology 2006; 213: 40–3.